GOODWILL AND OTHER INTANGIBLE ASSETS - Narrative (Details) $ in Millions |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
oncology_asset
|
Jun. 30, 2026
USD ($)
|
Jun. 30, 2025
USD ($)
|
|
| Other intangible assets | ||||
| Amortization of intangible assets | $ 471 | $ 864 | $ 943 | $ 1,700 |
| IPRD | ||||
| Other intangible assets | ||||
| IPRD impairment charge | $ 300 | |||
| Number of oncology assets | oncology_asset | 2 | |||
| Write-Down Of Oncology Asset And Radiopharmaceutical Asset Impairment | IPRD | ||||
| Other intangible assets | ||||
| IPRD impairment charge | $ 830 | |||
| Write-Down Of Oncology Asset Impairment | IPRD | ||||
| Other intangible assets | ||||
| IPRD impairment charge | $ 420 | |||
| X | ||||||||||
- Definition Number Of Oncology Assets No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of impairment loss for indefinite-lived intangible asset. Excludes goodwill. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|